Elite Pharmaceuticals ELTP
OTC ELTP
$0.24 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:00 AM EDT

Elite Pharmaceuticals (ELTP) Non-Current Debt (2011 - 2026)

Updated

Elite Pharmaceuticals' Non-Current Debt came in at $2.13 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 4.2% from $2.22 million a year earlier and down 1.1% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Non-Current Debt (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Non-Current Debt was $2.15 million, down 4.1% from FY2025.

  • Non-Current Debt has declined in each of the last three fiscal years, though with a five-year compound annual growth rate of 11.7% (FY2021 to FY2026).
  • Going back by fiscal year, Non-Current Debt was $2.25 million in FY2025 (-5.1%), $2.37 million in FY2024 (-6.6%), $2.53 million in FY2023 (+122.2%) and $1.14 million in FY2022 (-8.1%).
  • The fiscal Q1 2027 figure represents the lowest quarterly Non-Current Debt since fiscal Q4 2022.
  • Year-over-year, Non-Current Debt has declined for 13 consecutive quarters, with an average decline of 4.8% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Debt over five years came in fiscal Q1 2023 (growth of 896.4%), and the weakest in fiscal Q3 2024 (a decline of 83.8%).
  • Business Quant data shows ELTP's Non-Current Debt at $2.15 million (Q4 2026), $2.18 million (Q3 2026) and $2.2 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,133.02 Bn 1,101.60 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 616.49 Bn 535.01 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 62.48 Bn
4 Merck 366.78 Bn 321.16 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.96 Bn 261.95 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 23.68 Bn
7 Amgen 235.44 Bn 190.84 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.69 Bn 164.89 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.52 Bn 116.16 Bn 10.94 Bn 60.50 Bn
10 Elite Pharmaceuticals 262.85 Mn 144.52 Mn 13.51 Mn 2.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.13 Mn
Mar 31, 2026 2.15 Mn
Dec 31, 2025 2.18 Mn
Sep 30, 2025 2.20 Mn
Jun 30, 2025 2.22 Mn
Mar 31, 2025 2.25 Mn
Dec 31, 2024 2.27 Mn
Sep 30, 2024 2.30 Mn
Jun 30, 2024 2.33 Mn
Mar 31, 2024 2.37 Mn
Dec 31, 2023 2.41 Mn
Sep 30, 2023 2.45 Mn
Jun 30, 2023 2.55 Mn
Mar 31, 2023 2.53 Mn
Dec 31, 2022 14.82 Mn
Sep 30, 2022 14.51 Mn
Jun 30, 2022 12.40 Mn
Mar 31, 2022 1.14 Mn
Dec 31, 2021 1.14 Mn
Sep 30, 2021 1.13 Mn
API Access

Elite Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ELTP&period=max&api_key=YOUR_API_KEY